Prolonged or very frequent administration of the drug in young children can lead to inhibition of the central nervous system, hypothermia, coma, prolonged pupil dilation. Naphazoline can cause a sudden drop in blood pressure and tachycardia.
There are no data on acute overdose of droplets administered topically in the conjunctival sac.
Hypersensitivity.
Drowsiness, dry mouth, dizziness, nausea, headache, weakness, numbness of the mucous membranes, decreased reaction rate.
Drowsiness, dizziness, decreased reaction speed, headache, weakness, dry mouth, numbness in mucous membranes, nausea.
Increased excitability (especially in children).
Allergic diseases, allergodermatosis, peptic ulcer of the stomach and duodenum, insomnia, vomiting of pregnant women, Meniere syndrome, nausea, radiation disease, parkinsonism.
Allergic diseases, allergodermatosis, peptic ulcer of the stomach and duodenum, insomnia, vomiting of pregnant women, Meniere syndrome, nausea, radiation disease, parkinsonism.
Allergic reactions of the upper respiratory tract (nasal discharge, watery eyes, tickling in the throat or nose), cold.
Diphenhydramine
You should inform your doctor of any unpleasant reactions during treatment with BENALET®, such as: sedation, drowsiness, dizziness, decreased mucus secretion, constipation, dry mouth, urinary retention, nausea and vomiting.
When using BENALET®, you should avoid drinking alcohol. If you consume substantial amounts (large amounts) of alcohol and / or have a history of kidney or liver failure, BENALET® should be used with caution, following medical guidelines.
BENALET® mint and lemon honey flavors contain the yellow TARTRAZINE dye (FD&C no 5) which can cause allergic reactions, including bronchial asthma, especially in people allergic to acetylsalicylic acid.
Drug interactions of BenaletThe combination of BENALET® with other antitussives such as codeine is not advisable.
You should avoid using BENALET® in conjunction with :
- other products containing diphenhydramine hydrochloride, even those applied to the skin ;
- alcohol or monoaminoxidase inhibitors (eg.: selegiline, moclobemide), as blood pressure may drop and may interfere with the central nervous system and respiratory function ;
- antiarrhythmic drugs (eg.: disopyramine, sotalol).
The effect of diphenhydramine hydrochloride can be enhanced by other anticholinergic substances such as atropine, biperidene, tricyclic antidepressants (eg.: imipramine, amitriptyline) or monoaminoxidase inhibitors, which may result in life-threatening intestinal paralysis, urinary retention or acute elevation of intraocular pressure.
The use of diphenhydramine hydrochloride with other CNS depressant drugs such as hypnotics (eg.: alprazolam, phenobarbital), opioid analgesics (eg.: codeine, morphine) and alcohol can lead to an unpredictable potentiation of the effects of both drugs.
Use of Benalet in pregnancy and breastfeedingPregnancy: safety for use during pregnancy has not been established. BENALET® should only be used when the potential benefit outweighs the potential risk to the fetus and should not be used during the last 3 months of pregnancy, as diphenhydramine crosses the placenta. Newborns and premature babies can have serious reactions, such as seizures.
This medicine should not be used by pregnant women without medical or dental guidance.
Tell your doctor or dentist if you are using any other medicine.
In / M-1-5 ml of 1% solution.
Inside – 0.025 - 0.05 g (children – 0.01-0.03 g) 1-3 times a day. Course - 10-15 days.
Externally. Adults and children over 2 years old Benalet® apply to the affected areas of the skin (a 3-5 cm long gel strip on the affected area of the palm size) 3-4 times a day and distribute with light massage movements.
In / M-1-5 ml of 1% solution. Inside, adults-25-50 mg 1-3 times a day.
Children-10-30 mg 1-3 times a day. Course - 10-15 days.
Inside, adults - 2 tables. every 6 hours, but not more than 12 tables. per day.
Children from 6 to 12 years old - 1 table. (no more than 6) per day. Children under 6 need to see a doctor.
